Stendra (Avanafil) For Erectile Dysfunction Approved By FDA

Posted: Published on April 29th, 2012

This post was added by Dr P. Richardson

Editor's Choice Main Category: Erectile Dysfunction / Premature Ejaculation Also Included In: Urology / Nephrology;Regulatory Affairs / Drug Approvals Article Date: 28 Apr 2012 - 0:00 PDT

email to a friend printer friendly opinions

Current Article Ratings:

4.14 (7 votes)

2.5 (4 votes)

Stendra is a medication that is taken, when needed, 30 minutes before starting sexual activity. Doctors are advised to prescribe the lowest dose at which benefit is provided for the patients.

Victoria Kusiak, M.D., deputy director of the Office of Drug Evaluation III in the FDA's Center for Drug Evaluation and Research, said:

Stendra is a PDE5 (phosphodiesterase type 5) inhibitor, and increases blood flow to the penis. Patients taking nitrates should not be given this medication, the FDA emphasizes. Nitrates are often used to treat angina - combining Stendra with nitrates can bring about a sudden and severe drop in blood pressure.

In very rare cases, patients taking PDE5 inhibitors may experience color vision changes. On rarer occasions, patients may report sudden vision loss in one eye (and sometimes both). Some patients have reported loss of hearing, or decreased hearing. If you experience a sudden loss of hearing or vision you should cease taking any kind of PDE5 inhibitor, and see your doctor immediately.

The following side effects were reported by some patients during human studies: nasal congestion, common-cold symptoms, back pain, face redness, and headache. In rare cases patients may experience priapism - an erection that lasts for hours; in such cases medical help should be sought immediately.

Read more:
Stendra (Avanafil) For Erectile Dysfunction Approved By FDA

Related Posts
This entry was posted in Premature Ejaculation. Bookmark the permalink.

Comments are closed.